 |
His-His- Ile-Tyr-Leu-Gly-Ala-Val-Asn-Tyr-Ile-Tyr-NH2 |
|---|---|
| Trade Name | |
| Orphan Indication | Retinal detachment |
| USA Market Approval | USA |
| USA Designation Date | 2016-01-13 00:00:00 |
| Sponsor | ONL Therapeutics, Inc;1600 Huron Parkway, Second Floor;Ann Arbor, Michigan, 48109 |
